Weighted Average Number of Shares Outstanding, Diluted of RELMADA THERAPEUTICS, INC. from 31 Dec 2012 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
RELMADA THERAPEUTICS, INC. quarterly and annual Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 31 Dec 2012 to 30 Sep 2025.
  • RELMADA THERAPEUTICS, INC. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 30 Sep 2025 was 33,191,622, a 10% increase year-over-year.
  • RELMADA THERAPEUTICS, INC. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 30,163,751, a 0.21% increase from 2023.
  • RELMADA THERAPEUTICS, INC. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 30,099,203, a 1.6% increase from 2022.
  • RELMADA THERAPEUTICS, INC. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 29,628,664, a 69% increase from 2021.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

RELMADA THERAPEUTICS, INC. Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 33,191,622 +3,017,420 +10% 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 33,191,622 +3,017,420 +10% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 30,408,890 +276,720 +0.92% 01 Jan 2025 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 30,163,751 +64,548 +0.21% 01 Oct 2024 31 Dec 2024 10-K 27 Mar 2025 2024 FY
Q3 2024 30,174,202 +74,999 +0.25% 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2025 2025 Q3
Q2 2024 30,174,202 +74,999 +0.25% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025 2025 Q2
Q1 2024 30,132,170 +32,967 +0.11% 01 Jan 2024 31 Mar 2024 10-Q 12 May 2025 2025 Q1
Q4 2023 30,099,203 +470,539 +1.6% 01 Oct 2023 31 Dec 2023 10-K 27 Mar 2025 2024 FY
Q3 2023 30,099,203 +35,468 +0.12% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024 2024 Q3
Q2 2023 30,099,203 +163,308 +0.55% 01 Apr 2023 30 Jun 2023 10-Q 07 Aug 2024 2024 Q2
Q1 2023 30,099,203 +1,706,602 +6% 01 Jan 2023 31 Mar 2023 10-Q 08 May 2024 2024 Q1
Q4 2022 29,628,664 +12,075,926 +69% 01 Oct 2022 31 Dec 2022 10-K 19 Mar 2024 2023 FY
Q3 2022 30,063,735 +12,585,258 +72% 01 Jul 2022 30 Sep 2022 10-Q 08 Nov 2023 2023 Q3
Q2 2022 29,935,895 +12,881,249 +76% 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023 2023 Q2
Q1 2022 28,392,601 +11,819,929 +71% 01 Jan 2022 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 17,552,738 01 Oct 2021 31 Dec 2021 10-K 23 Mar 2023 2022 FY
Q3 2021 17,478,477 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022 2022 Q3
Q2 2021 17,054,646 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022 2022 Q2
Q1 2021 16,572,672 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022 2022 Q1
Q1 2017 12,035,912 +32,123 +0.27% 01 Jan 2017 31 Mar 2017 10-Q 15 May 2017 2017 Q3
Q4 2016 12,035,912 +615,733 +5.4% 01 Oct 2016 31 Dec 2016 10-Q 10 Feb 2017 2017 Q2
Q3 2016 12,035,335 -902,050 -7% 01 Jul 2016 30 Sep 2016 10-Q 10 Nov 2016 2017 Q1
Q1 2016 12,003,789 +1,264,460 +12% 01 Jan 2016 31 Mar 2016 10-Q 15 May 2017 2017 Q3
Q4 2015 11,420,179 -2,667,227 -19% 01 Oct 2015 31 Dec 2015 10-Q 10 Feb 2017 2017 Q2
Q3 2015 12,937,385 +4,791,955 +59% 01 Jul 2015 30 Sep 2015 10-Q 10 Nov 2016 2017 Q1
Q1 2015 10,739,329 -198,867,640 -95% 01 Jan 2015 31 Mar 2015 10-Q 09 May 2016 2016 Q3
Q4 2014 14,087,406 01 Oct 2014 31 Dec 2014 10-Q 05 Feb 2016 2016 Q2
Q3 2014 8,145,430 01 Jul 2014 30 Sep 2014 10-Q 06 Nov 2015 2016 Q1
Q1 2014 209,606,969 +185,583,135 +772% 01 Jan 2014 31 Mar 2014 8-K 27 May 2014 2014 Q3
Q1 2013 24,023,834 01 Jan 2013 31 Mar 2013 8-K 27 May 2014 2014 Q3

RELMADA THERAPEUTICS, INC. Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 30,163,751 +64,548 +0.21% 01 Jan 2024 31 Dec 2024 10-K 27 Mar 2025 2024 FY
2023 30,099,203 +470,539 +1.6% 01 Jan 2023 31 Dec 2023 10-K 27 Mar 2025 2024 FY
2022 29,628,664 +12,075,926 +69% 01 Jan 2022 31 Dec 2022 10-K 19 Mar 2024 2023 FY
2021 17,552,738 01 Jan 2021 31 Dec 2021 10-K 23 Mar 2023 2022 FY
2013 24,292,670 +2,627,696 +12% 01 Jan 2013 31 Dec 2013 8-K 27 May 2014 2014 Q3
2012 21,664,974 01 Jan 2012 31 Dec 2012 8-K 27 May 2014 2014 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.